Loading...

Mangoceuticals, Inc.

MGRX•NASDAQ
Healthcare
Medical - Healthcare Information Services
$0.42
$0.01(3.17%)
U.S. Market opens in 44h 12m

Mangoceuticals, Inc. (MGRX) Stock Overview

Explore Mangoceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.4M
P/E Ratio-0.21
EPS (TTM)$-2.17
ROE-1.17%
Fundamental Analysis

AI Price Forecasts

1 Month$1.11
3 Months$0.00
1 Year Target$0.00

MGRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mangoceuticals, Inc. (MGRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.94, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.21 and a market capitalization of 4.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.17%
5-Day Change
-9.72%
1-Month Change
37.48%
3-Month Change
-18.58%
6-Month Change
-82.10%
Year-to-Date (YTD) Change
-43.64%
1-Year Change
-80.14%
3-Year Change
-98.57%
5-Year Change
-99.30%
All-Time (Max) Change
-99.30%

Contact Information

https://www.mangorx.com
(214) 242-9619
15110 North Dallas Parkway, Dallas, TX, 75248

Company Facts

3 Employees
IPO DateMar 21, 2023
CountryUS
Actively Trading

Frequently Asked Questions